EV/EBITDA
14.20
+0.03+0.21%
3 min ago
Summary:
Regeneron Pharmaceuticals EV/EBITDA is currently 14.20, with a rise of +0.03 (+0.21%) during the most recent trading day. Over the past year, it has dropped by -4.85 (-25.46%). REGN EV/EBITDA is now -99.33% below its all-time high of 2125.69.REGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +0.2% |
1 m1 month | -5.3% |
3 m3 months | -43.0% |
6 m6 months | -44.3% |
ytdytd | -30.4% |
1 y1 year | -25.5% |
5 y5 years | -14.4% |
REGN EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 15.86 | -10.5% | 14.17 | +0.2% |
3 m | 3 months | 24.93 | -43.0% | 14.17 | +0.2% |
6 m | 6 months | 26.04 | -45.5% | 14.17 | +0.2% |
1 y | 1 year | 26.04 | -45.5% | 14.17 | +0.2% |
3 y | 3 years | 26.04 | -45.5% | 6.28 | +126.1% |
5 y | 5 years | 26.04 | -45.5% | 6.28 | +126.1% |
alltime | all time | 2125.69 | -99.3% | -131.56 | +110.8% |
Regeneron Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2024 | 14.20(-30.4%) |
2023 | 20.40(+36.3%) |
2022 | 14.97(+111.4%) |
2021 | 7.08(-44.3%) |
2020 | 12.71(-16.2%) |
2019 | 15.17(+3.6%) |
2018 | 14.64(-18.4%) |
2017 | 17.94(-33.4%) |
2016 | 26.95(-37.2%) |
2015 | 42.89(-12.7%) |
2014 | 49.14(+40.6%) |
2013 | 34.96(+2.9%) |
2012 | 33.97(-213.7%) |
2011 | -29.88(-24.2%) |
2010 | -39.43(+13.5%) |
2009 | -34.75(+65.9%) |
2008 | -20.95(+7.1%) |
Date | Value |
---|---|
2007 | -19.56(+42.8%) |
2006 | -13.70(-310.1%) |
2005 | 6.52(-77.9%) |
2004 | 29.48(-380.5%) |
2003 | -10.51(+26.3%) |
2002 | -8.32(-44.4%) |
2001 | -14.96(-60.9%) |
2000 | -38.23(+112.7%) |
1999 | -17.97(-19.9%) |
1998 | -22.44(-12.7%) |
1997 | -25.69(-25.9%) |
1996 | -34.66(-66.0%) |
1995 | -102.08(+5539.8%) |
1994 | -1.81(-77.1%) |
1993 | -7.89(-25.9%) |
1992 | -10.65(-77.0%) |
1991 | -46.37 |
FAQ
- What is Regeneron Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Regeneron Pharmaceuticals?
- What is REGN EV/EBITDA year-to-date change?
- What is Regeneron Pharmaceuticals EV/EBITDA year-on-year change?
What is Regeneron Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of REGN is 14.20
What is the all time high EV/EBITDA for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high EV/EBITDA is 2125.69
What is REGN EV/EBITDA year-to-date change?
Regeneron Pharmaceuticals EV/EBITDA has changed by -6.20 (-30.39%) since the beginning of the year
What is Regeneron Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, REGN EV/EBITDA has changed by -4.85 (-25.46%)